Logotype for Atomo Diagnostics Limited

Atomo Diagnostics (AT1) investor relations material

Atomo Diagnostics H2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Atomo Diagnostics Limited
H2 2025 earnings summary2 Sep, 2025

Executive summary

  • Achieved significant improvement in gross margin to 51% from 39% year-over-year, driven by a shift away from lower-margin Global Health HIV business and cost reduction strategies.

  • Revenue for FY2025 was $3.79 million, broadly in line with the prior year but down 7% from FY24, with improved profitability metrics and reduced EBITDA loss by 23% to $3.37 million.

  • Raised just under $3 million in new capital, mainly from existing shareholders, and ended the year with $3.22 million in cash and no debt.

  • Expanded commercial activities with major HIV self-test orders, a $2.44 million government grant for Active Syphilis test development, and new OEM agreements.

  • Board refresh with new directors, resignations, and reduced annual board costs.

Financial highlights

  • FY2025 revenue was $3.79 million, down 7% year-over-year, with gross margin improving to 51% from 39%.

  • Gross profit rose 19% to $1.92 million, and underlying EBITDA loss reduced by 23% to $3.37 million.

  • Operating expenses decreased by $650,000, reflecting ongoing cost-saving initiatives.

  • Cash on hand at June 30 was $3.22 million, with an additional $1.32 million raised post year-end; no debt.

  • Net cash outflow was within expectations, with $8.7 million in receipts and $9.1 million in payments.

Outlook and guidance

  • Focus remains on margin expansion, cost efficiency, and operational leverage, with no significant CapEx required for future revenue growth.

  • Anticipated Pascal revenues of up to US$6.9 million over three years, with further ramp-up expected.

  • Commercial path to market for Active Syphilis test in Australia and Europe targeted for early CY 2027, seeking a U.S. partner.

  • Expects further growth in HIV and syphilis test sales, especially in Australia, Europe, and new markets.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Atomo Diagnostics earnings date

Logotype for Atomo Diagnostics Limited
Q1 2026 TU30 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Atomo Diagnostics earnings date

Logotype for Atomo Diagnostics Limited
Q1 2026 TU30 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Atomo Diagnostics Limited provides products in the areas of cancer, infectious diseases, and cardiovascular ailments. Its tests include Visca for diagnosing liver cancer and liver fibrosis/cirrhosis; MammaScreen for early breast cancer detection through measurements of plasma proteins (by testing blood); Chlamydia Screen for the screening or confirmation of Chlamydia trachomatis infections; HIV-1Virology Test System for the qualitative detection of antibodies to human immunodeficiency virus type 1 (HIV-1); and AtomoRapid Malaria Test that detects malaria infection in whole blood samples. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage